02:08 PM EDT, 03/12/2024 (MT Newswires) -- Aileron Therapeutics ( ALRN ) named Brian Windsor as chief executive officer, starting Monday.

Windsor is currently the company's president and chief operating officer. He joined the board of directors the same day and will continue as president, Aileron said Tuesday.

Windsor succeeds Manuel Aivado as CEO. Aivado will continue to serve on the company's board.

Windsor became Aileron's president and COO in October, following the company's acquisition of Lung Therapeutics.

Aileron Therapeutics ( ALRN ) shares fell past 4% in recent trading.

Price: 5.33, Change: -0.25, Percent Change: -4.48